PET Imaging as a Tool for Assessing COVID-19 Brain Changes

Area of Science:

• Neuroscience
• Infectious Diseases
• Medical Imaging

Background:

• A significant number of patients with coronavirus disease 2019 (COVID-19) present with neurological symptoms.
• The specific brain alterations induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not well understood.
• Understanding these changes is crucial for managing neurological complications of COVID-19.

Purpose of the Study:

• To provide an overview of how positron emission tomography (PET) can be utilized.
• To explore the potential of PET applications in elucidating central nervous system (CNS) pathophysiological changes in SARS-CoV-2 infection.
• To highlight PET's role in advancing the understanding of neuro-COVID-19.

Main Methods:

• Review of current literature on PET imaging techniques.
• Discussion of established PET tracers and their relevance to neuroinflammation, metabolism, and receptor occupancy.
• Exploration of novel PET strategies for studying viral infections in the brain.

Main Results:

• PET imaging offers a non-invasive method to visualize and quantify biological processes in the brain.
• Specific PET tracers can detect neuroinflammation, altered glucose metabolism, and changes in neurotransmitter systems relevant to neurological manifestations.
• PET can potentially differentiate between direct viral effects, indirect inflammatory responses, and secondary complications in the CNS.

Conclusions:

• Positron emission tomography presents a powerful tool for investigating the neurological impact of SARS-CoV-2.
• PET applications can significantly enhance our comprehension of the underlying brain pathophysiology in COVID-19.
• Further research utilizing PET is warranted to fully characterize CNS alterations and guide therapeutic strategies for neuro-COVID-19.